# The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis

> **NCT02480335** · PHASE4 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 20 (actual)

## Conditions studied

- Scleroderma, Systemic

## Interventions

- **DRUG:** bosentan

## Key facts

- **NCT ID:** NCT02480335
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-26
- **Primary completion:** 2018-07-30
- **Final completion:** 2018-07-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02480335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02480335, "The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02480335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*